- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Unanimous Approval by House Panel for 21st Century Cures Bill
The 21st Century Cures bill is a bipartisan initiative that is aimed to streamline and hasten the drug and device approval process and promote medical innovation.
Initiated by a collaborative effort between Fred Upton (R-Mich) and Diana DeGette (D-Colo), provisions of the 21st Century Cures Initiative would provide support to the FDA and the National Institutes of Health, so medical innovations made be scientists find the light of day.
On Thursday, The House Energy and Commerce Committee, chaired by Upton, unanimously approved the bill shortly after reaching a bipartisan $13 billion deal to pay for the legislation.
Several professional organizations are now providing their response to the bills provisions.
Read the complete article on The Hill: http://bit.ly/1AjOR2u
Eculizumab Biosimilar ABP 959 Demonstrates Similarity to Reference in Patients With PNH
December 6th 2023ABP 959, an eculizumab biosimilar in development, has demonstrated similar efficacy and pharmacokinetics to the reference product for patients with paroxysmal nocturnal hemoglobinuria (PNH), according to research at the 2023 American Society of Hematology Annual Meeting.
Read More
Humana Report Shows Benefits of Value-Based Care for Patients, Physicians
December 6th 2023Patients seen at value-based care clinics received more preventive screenings and had lower risks of hospitalization and emergency room visits, according to Humana’s 10th annual value-based care report.
Read More
Race/Ethnicity May Influence Local Recurrence in DCIS, Adjuvant Treatment
December 6th 2023Disparities in 10-year local recurrence following breast-conserving surgery were seen among women with ductal carcinoma in situ (DCIS) treated over a nearly 4-decade span at Memorial Sloan Kettering Cancer Center, with Black women having the highest rate.
Read More
